J. Hagan Capital’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History
Bought
Maintained
Sold
Other funds holding BTAL
FDCDDQ
OIA
WIA
CCMG
J. Hagan Capital's BTAL Position: Q3 2025 in Review
J. Hagan Capital sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q3 2025, closing a stake of 14,385 shares — an estimated $240K sold.
J. Hagan Capital first reported a position in BTAL in Q2 2025 and held it in 1 quarter. The position peaked at $240K in Q2 2025. 71 funds tracked by Wall St. Rank hold BTAL as of Q3 2025.
- J. Hagan Capital reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q3 2025 after selling out during the quarter.
- J. Hagan Capital sold 14,385 AGF US Market Neutral Anti-Beta Fund shares in Q3 2025, an estimated $240K.
- J. Hagan Capital first reported a position in AGF US Market Neutral Anti-Beta Fund in Q2 2025 and held it in 1 quarter.
- J. Hagan Capital's AGF US Market Neutral Anti-Beta Fund position peaked at $240K in Q2 2025.
- 71 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q3 2025.
Based on J. Hagan Capital's 13F filing for Q3 2025, filed 13 Nov 2025.